Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK, Jan. 10, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming…
Monthly information related to total number of voting rights and shares composing…
After a transformative year in 2021, NGM Bio enters 2022 with a diverse pipeline of seven disclosed programs, including four…
LAKE FOREST, Ill., Jan. 10, 2022 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT) today announced…
Artelo CEO also providing corporate outlook for 2022 at the H.C. Wainwright ConferenceSOLANA BEACH, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE)…
Delivery of 100,000 samples of capacity annually to the market, empowering genomics researchers to add deep, unbiased proteomics analysis to…
Castellum, Inc. Announces Promotion of Glen Ives to President of Government Sales and Operations; Additional Executive Moves Noted Castellum, Inc.…
Exploring natural products for innovative therapeuticsSAN FRANCISCO, Jan. 09, 2022 (GLOBE NEWSWIRE) — Biotechnology company Zymergen (ZY) announced a new…
Superhero cells are key to the efficacy, potency, and durability of therapies across the human health spectrumBRANFORD, Conn., Jan. 09,…
— HMPL-760 is the eleventh innovative potential oncology drug candidate discovered in-house by HUTCHMED — — HMPL-760 is HUTCHMED’s fifth candidate in…